What is the recommended dosing of tadalafil for erectile dysfunction and pulmonary arterial hypertension, and what are its contraindications and precautions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tadalafil Dosing and Clinical Guidance

Erectile Dysfunction

For erectile dysfunction, start with tadalafil 10 mg taken as needed prior to sexual activity, with dose adjustment between 5-20 mg based on response and tolerability 1. The American College of Physicians strongly recommends initiating PDE-5 inhibitor therapy for men seeking ED treatment without contraindications 2.

Dosing Strategies

As-Needed Dosing:

  • Starting dose: 10 mg prior to anticipated sexual activity
  • Dose range: 5-20 mg
  • Maximum frequency: Once daily
  • Duration of effect: Up to 36 hours 1

Daily Dosing:

  • Starting dose: 2.5 mg once daily at the same time each day
  • May increase to 5 mg daily based on efficacy and tolerability
  • Taken without regard to timing of sexual activity 1

The choice between as-needed versus daily dosing should be based on frequency of sexual activity and patient preference. Daily dosing at 5 mg has demonstrated sustained efficacy and excellent tolerability over 1-2 years 3, and may offer additional benefits for endothelial function 4.

Pulmonary Arterial Hypertension

For PAH, the recommended dose is tadalafil 40 mg once daily, which is the only dose that demonstrated statistically significant improvement in exercise capacity and clinical outcomes 5, 6. The 2015 ESC/ERS guidelines support tadalafil use in PAH based on favorable results in exercise capacity, symptoms, hemodynamics, and time to clinical worsening 5.

The pivotal trial showed that tadalafil 40 mg:

  • Increased 6-minute walk distance by 33 meters (placebo-corrected)
  • Reduced clinical worsening by 68% relative risk reduction
  • Improved quality of life measures
  • Was effective both as monotherapy and on background bosentan therapy 6

Dose Adjustments for Special Populations

Renal Impairment

As-Needed Dosing:

  • CrCl 30-50 mL/min: Start 5 mg, maximum 10 mg once every 48 hours
  • CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1

Daily Dosing for ED:

  • CrCl <30 mL/min or hemodialysis: Not recommended 1

Daily Dosing for BPH/ED+BPH:

  • CrCl 30-50 mL/min: Start 2.5 mg, may increase to 5 mg
  • CrCl <30 mL/min or hemodialysis: Not recommended 1

Hepatic Impairment

Mild to Moderate (Child-Pugh A or B):

  • As-needed: Maximum 10 mg once daily
  • Daily dosing: Use with caution, not extensively studied 1

Severe (Child-Pugh C):

  • Not recommended for any indication 1

Absolute Contraindications

Tadalafil is absolutely contraindicated with concurrent nitrate use in any form 1, 7. This includes:

  • Sublingual, oral, transdermal, or intravenous nitroglycerin
  • Isosorbide mononitrate or dinitrate
  • Recreational nitrates ("poppers")

The combination can cause severe, potentially life-threatening hypotension. In patients with coronary artery disease, tadalafil 5-10 mg followed by sublingual nitroglycerin resulted in mean maximal standing systolic blood pressure drops of 28-36 mm Hg 7.

Critical Precautions

Alpha-Blocker Coadministration

When prescribing tadalafil for ED in patients on alpha-blockers:

  • Patients must be stable on alpha-blocker therapy first
  • Initiate tadalafil at the lowest recommended dose 1

Cardiovascular Considerations

Tadalafil produces small, generally non-clinically significant blood pressure decreases in healthy subjects 7. However, exercise caution in:

  • Patients with active coronary artery disease
  • Those with recent cardiovascular events
  • Patients with uncontrolled hypertension or hypotension

The cardiac mortality and myocardial infarction rates in tadalafil studies were actually lower than placebo and comparable to age-standardized populations 7, suggesting acceptable cardiovascular safety when used appropriately.

Common Pitfalls to Avoid

  1. Do not split tablets - the entire dose must be taken 1

  2. Do not prescribe daily dosing for severe renal impairment - only as-needed dosing with extended intervals is appropriate 1

  3. Do not use inadequate doses for PAH - only 40 mg daily has proven efficacy; lower doses did not meet statistical significance 6

  4. Do not overlook drug interactions - particularly with CYP3A4 inhibitors and nitrates

  5. For ED, do not automatically choose the highest dose - start at 10 mg as-needed or 2.5 mg daily and titrate based on response 2, 1

Side Effect Profile

The most common adverse events are mild to moderate and vasodilation-related:

  • Headache
  • Flushing
  • Myalgia
  • Back pain
  • Dyspepsia 5, 6

The side effect profile is similar across all PDE-5 inhibitors and generally well-tolerated 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.